Innovation Pharmaceuticals Inc (IPIX)
0.0015
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Innovation Pharmaceuticals 1 Year Total Returns (Daily): -91.53% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | -91.53% |
May 16, 2024 | -92.35% |
May 15, 2024 | -91.57% |
May 14, 2024 | -92.57% |
May 13, 2024 | -88.57% |
May 10, 2024 | -95.65% |
May 09, 2024 | -96.09% |
May 08, 2024 | -98.00% |
May 07, 2024 | -97.78% |
May 06, 2024 | -97.78% |
May 03, 2024 | -87.50% |
May 02, 2024 | -88.49% |
May 01, 2024 | -85.47% |
April 30, 2024 | -92.17% |
April 29, 2024 | -86.95% |
April 26, 2024 | -85.00% |
April 25, 2024 | -89.69% |
April 24, 2024 | -86.70% |
April 23, 2024 | -81.03% |
April 22, 2024 | -77.24% |
April 19, 2024 | -78.01% |
April 18, 2024 | -43.89% |
April 17, 2024 | -48.32% |
April 16, 2024 | 5.36% |
April 15, 2024 | -10.71% |
Date | Value |
---|---|
April 12, 2024 | -24.42% |
April 11, 2024 | -30.43% |
April 10, 2024 | -32.02% |
April 09, 2024 | -32.00% |
April 08, 2024 | -32.57% |
April 05, 2024 | -29.73% |
April 04, 2024 | -29.65% |
April 03, 2024 | -25.13% |
April 02, 2024 | -25.00% |
April 01, 2024 | -30.00% |
March 28, 2024 | -32.94% |
March 27, 2024 | -37.78% |
March 26, 2024 | -35.05% |
March 25, 2024 | -30.95% |
March 22, 2024 | -32.00% |
March 21, 2024 | -34.23% |
March 20, 2024 | -36.79% |
March 19, 2024 | -36.00% |
March 18, 2024 | -37.00% |
March 15, 2024 | -18.22% |
March 14, 2024 | -17.19% |
March 13, 2024 | 0.59% |
March 12, 2024 | -14.47% |
March 11, 2024 | -21.71% |
March 08, 2024 | -21.58% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-98.00%
Minimum
May 08 2024
535.0%
Maximum
Feb 08 2021
-15.20%
Average
-48.61%
Median
Jan 13 2020
1 Year Total Returns (Daily) Benchmarks
AIM ImmunoTech Inc | -19.40% |
Perspective Therapeutics Inc | 252.7% |
Protalix BioTherapeutics Inc | -51.69% |
Electromed Inc | 32.31% |
Armata Pharmaceuticals Inc | 107.2% |